Liver cT(1) decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus

PURPOSE: Direct-acting antiviral therapies (DAAs) for treatment of chronic hepatitis C virus (HCV) have excellent rates of viral eradication, but their effect on regression of liver fibrosis is unclear. The primary aim was to use magnetic resonance imaging (MRI) and spectroscopy (MRS) to evaluate ch...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Abdom Radiol (NY)
Main Authors: Jayaswal, Arjun N. A., Levick, Christina, Collier, Jane, Tunnicliffe, Elizabeth M., Kelly, Matthew D., Neubauer, Stefan, Barnes, Eleanor, Pavlides, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2020
Assuntos:
Hepatobiliary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8131342/
https://ncbi.nlm.nih.gov/pubmed/33247768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00261-020-02860-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados